|
⚲
|
| Keyboard |
| Christopher Ford | |
|---|---|
| Firm | |
| Address | Towers Watson Investment Management Ltd 51 Lime Street London, X0 EC3M 7DQ |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| 3DERM Systems Inc | 021-344794 | Director | 0.5 M of 0.5 M |
||
| Ourlyhelp Inc | 021-303647 | Executive Officer | 4.3 M of 6.6 M |
||
| UV Light Care Inc | 021-270584 | Executive Officer | 0.5 M of 0.5 M |
||
| American Renal Associates Holdings Inc | 021-168271 | Executive Officer | 9.4 M of 9.4 M |
||
| CP Atlas Holdings Inc | 021-146635 | Director | 2.8 M of 2.8 M |
||
| Medscience Ventures LLC | |||||
| Medscience Ventures LP | 021-267132 | Executive Officer | 4.6 M of 10.0 M |
4.7 M | |
| Towers Watson Investment Management Limited | |||||
| Towers Watson Alternative Credit Master Fund | 021-253604 | Director | 486.2 M | 3,735.6 M | |
| Towers Watson Diversifying Strategies Master Fund | 021-208064 | Director | 919.1 M | 281.6 M | |
| Towers Watson Hedge Advantage Master Fund | 021-208046 | Director | 564.7 M | 586.3 M | |